Japan-based Astellas Pharma and US-based startup Propella Therapeutics have entered into a merger agreement pursuant to ...
Japan-based University of Tsukuba and Astellas Pharma have signed a letter of confirmation regarding a strateg...
Japan-based iPark Institute has announced the signing of a groundbreaking business agreement with South Korea's Small an...
Japanese firm Fujitsu has signed a General Action Protocol with the Regional Government of Andalusia, Spain to establish...
Daiichi Sankyo Europe GmbH, the European headquarter organisation of the Japanese pharmaceutical company Daiichi Sankyo ...
Duke-NUS Medical School (Duke-NUS) in Singapore and IPGaia, Inc. (IPG) in Japan have signed an agreement to jointly adva...
Japan-headquartered Global Health Innovative Technology Fund (GHIT Fund) and Switzerland-based Medicines Patent Pool (MP...
Japan based Shionogi and US based Apnimed, Inc. have agreed to establish a joint venture (JV) company, Shionogi-Apnimed ...
I Peace, Inc., specialising in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies based in Palo Alto...
Japan-headquartered pharmaceutical company Daiichi Sankyo's Board has passed a resolution on the basic policy for ...
US-based startup AnHeart Therapeutics has entered into an exclusive license agreement with Nippon Kayaku to market ...
Japan-based companies Sumitomo Pharma and AlphaNavi Pharma have announced that AlphaNavi has exercised its option rights...
Debiopharm International SA, Yakult Honsha and Takata Pharmaceutical have agreed that Yakult Honsha will transfer ...
Mithra Biotech, a company dedicated to women’s health, has announced that its licence holder Fuji Pharma has submi...
Japan-headquartered firm Shimadzu Corporation has launched the “Urina” integrated management type urine volu...
Japanese pharmaceutical firm Daiichi Sankyo and US-based life sciences company Merck (known as MSD outside of the United...
Japan-based companies Fujitsu and TOPPAN Holdings Inc. have concluded a business alliance agreement to jointly promote t...
British medtech company Smith+Nephew has announce the launch of its REGENETEN Bioinductive Implant allowing access to th...
